Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rikkunshito for Chemotherapy-Induced Nausea and Vomiting in Uterine Cancer
jRCT1011190007Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jan 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in chemotherapy-induced nausea and vomiting (CINV) comparing Rikkunshito arm with Placebo arm (2 arms). Primary endpoint: Complete response (CR) rate during delayed phase. Started Jan 2020; status: completed.
02
Drugs
rikkunshito
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on jRCT1011190007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1011190007.